249 related articles for article (PubMed ID: 35863515)
1. The role of imaging in targeted delivery of nanomedicine for cancer therapy.
Li P; Wang D; Hu J; Yang X
Adv Drug Deliv Rev; 2022 Oct; 189():114447. PubMed ID: 35863515
[TBL] [Abstract][Full Text] [Related]
2. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
3. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles for tumor targeting delivery based on five features principle.
Yong T; Wang D; Li X; Yan Y; Hu J; Gan L; Yang X
J Control Release; 2020 Jun; 322():555-565. PubMed ID: 32246977
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography image-guided drug delivery: current status and future perspectives.
Chakravarty R; Hong H; Cai W
Mol Pharm; 2014 Nov; 11(11):3777-97. PubMed ID: 24865108
[TBL] [Abstract][Full Text] [Related]
6. Companion Diagnostic
Lee H; Gaddy D; Ventura M; Bernards N; de Souza R; Kirpotin D; Wickham T; Fitzgerald J; Zheng J; Hendriks BS
Theranostics; 2018; 8(9):2300-2312. PubMed ID: 29721081
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
Braga CB; Perli G; Becher TB; Ornelas C
Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
[TBL] [Abstract][Full Text] [Related]
8. Porphyrin-Based Nanomedicines for Cancer Treatment.
Xue X; Lindstrom A; Li Y
Bioconjug Chem; 2019 Jun; 30(6):1585-1603. PubMed ID: 31023011
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
10. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
11. Imaging-guided revival of nanomedicine?
Senders ML; Fayad ZA; Reiner T; Mulder WJ; Pérez-Medina C
Nanomedicine (Lond); 2017 Jan; 12(2):89-90. PubMed ID: 27876441
[No Abstract] [Full Text] [Related]
12. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.
Vallabani NVS; Singh S; Karakoti AS
Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498
[TBL] [Abstract][Full Text] [Related]
14. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.
de Maar JS; Sofias AM; Porta Siegel T; Vreeken RJ; Moonen C; Bos C; Deckers R
Theranostics; 2020; 10(4):1884-1909. PubMed ID: 32042343
[TBL] [Abstract][Full Text] [Related]
15. Using imaging modalities to predict nanoparticle distribution and treatment efficacy in solid tumors: The growing role of ultrasound.
Cooley MB; Wegierak D; Exner AA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1957. PubMed ID: 38558290
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
17. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
18. Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: Implications on the design of nanomedicine.
Tian Y; Cheng T; Sun F; Zhou Y; Yuan C; Guo Z; Wang Z
Adv Colloid Interface Sci; 2024 Apr; 326():103124. PubMed ID: 38461766
[TBL] [Abstract][Full Text] [Related]
19. Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers.
Yang J; Wang X; Wang B; Park K; Wooley K; Zhang S
Adv Drug Deliv Rev; 2022 Nov; 190():114525. PubMed ID: 36100142
[TBL] [Abstract][Full Text] [Related]
20. Targeted Magnetic Nanotheranostics of Cancer.
Belyanina I; Kolovskaya O; Zamay S; Gargaun A; Zamay T; Kichkailo A
Molecules; 2017 Jun; 22(6):. PubMed ID: 28604617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
